P lasma high-density lipoprotein (HDL) levels correlate inversely with the incidence of cardiovascular disease in humans. 1 Although the causative nature of this association in humans has been called into question by Mendelian randomization studies, 2 abundant evidence in animal models and limited evidence in humans indicate that increased production or infusion of HDL is antiatherogenic. 3-8 A plethora of antiatherogenic mechanisms has been invoked to explain these beneficial effects of HDL 9-11 ; however, relatively few of these have been adequately tested in vivo.
pathways in atherosclerosis has not been directly tested, and a variety of alternative protective effects of HDL on endothelial function have been proposed. 25, 26 Various cholesterol efflux pathways have been shown to operate in cultured ECs including those mediated by scavenger receptor BI, passive diffusion, and the ABCA1 and ATP-binding cassette transporter G1 (ABCG1). 17, 18 ABCA1 and ABCG1 mediate cholesterol efflux to apolipoprotein A1 and HDL, respectively. 18, 24, 27 Studies in human aortic ECs (HAECs) have shown high expression of ABCG1 but not ABCA1, 18 and our studies in cultured mouse ECs have suggested a predominant role of ABCG1 in preservation of endothelial function. 18, 24 An atheroprotective effect of vascular ABCG1 was suggested by transplantation of Abcg1 +/+ bone marrow (BM) into mice with whole body Abcg1 deficiency on the Ldlr −/− background, 28 and ABCG1 was shown to have a major role in suppressing proatherogenic VCAM-1 expression in ECs. 29 However, these studies did not directly test the role of endothelial ABCG1 in endothelial inflammation and atherosclerosis in vivo. Moreover, endothelial Abca1 as well as Abcg1 expression is upregulated by laminar blood flow in the thoracic aorta in mice, 30 and endothelial Abca1 expression is upregulated in the aortic arch by treatment with a proatherogenic stimulus. 31 Thus, there could be roles for both ABC transporters in preservation of endothelial functions in vivo. Relevant functions suggested by previous studies include preservation of arterial eNOS activity and suppression of endothelial inflammation. 18, 24, 29 In addition, elegant studies in the zebrafish model have demonstrated roles for ABCA1 and ABCG1 in the suppression of angiogenesis. 32 We have developed Abca1 fl/fl and Abcg1 fl/fl mice, 33 allowing us to address the role of cell-specific pathways mediating cholesterol efflux in atherosclerosis. The goals of this study were to assess the impact of deleting endothelial ABCA1 and ABCG1 on atherogenesis and to assess the relevance of potential antiatherogenic mechanisms. 18, 24, 29, 32 
Materials and Methods
Materials and Methods are available in the online-only Data Supplement. We attempted to develop an endothelium-specific Abca1/ g1-deficient mouse model, by crossbreeding Abca1 fl/fl Abcg1 fl/fl mice with mice expressing the endothelium-specific VecadherinCre promoter (also referred to as Cdh5Cre) 34 to generate VecadherinCreAbca1 fl/fl Abcg1 fl/fl and Abca1 fl/fl Abc-g1 fl/fl mice. However, VecadherinCreAbca1 fl/fl Abcg1 fl/fl mice did not show reduced ABCA1 and ABCG1 protein expression in ECs compared with their littermate Abca1 fl/fl Abcg1 fl/fl controls ( Figure I in the online-only Data Supplement). We therefore crossbred Abca1 fl/fl Abcg1 fl/fl mice with mice expressing the endothelium-specific Tie2Cre promoter. 35 We found that ABCA1 and ABCG1 protein levels were reduced by >90% in Tie2CreAbca1 fl/fl Abcg1 fl/fl mouse lung ECs as compared with littermate Abca1 fl/fl Abcg1 fl/fl controls ( Figure 1A and 1B; Figure II in the online-only Data Supplement). In mouse aortic ECs, Abca1 and Abcg1 mRNA expression were reduced by >90% in ECs isolated from Tie2CreAbca1 fl/fl Abc-g1 fl/fl mice compared with littermate Abca1 fl/fl Abcg1 fl/fl controls ( Figure 1C ). In line with several other models, [35] [36] [37] ABCA1 and ABCG1 protein expression were reduced by >90% in 
Results

ABCA1 and ABCG1 Expression in
EC-Abca1 and Abcg1 Deficiency Increases Cholesterol Accumulation and Accelerates Atherosclerosis
We first evaluated whether EC-Abca1 and Abcg1 deficiency affected cholesterol accumulation. We fed EC-ABC DKO Ldlr −/− and Ldlr −/− mice the Western-type diet (WTD) for 12 weeks and isolated ECs. Abca1/g1 deficiency increased EC cholesterol accumulation by ≈25% ( Figure 2B ), which reflected an increase in free cholesterol accumulation, as free cholesterol and total cholesterol levels were similar (results not shown). Abca1/g1 deficiency decreased cholesterol efflux to apolipoprotein A1 and HDL in ECs ( Figure 2B ), suggesting a role for both ABCA1 and ABCG1 in mediating cholesterol efflux from ECs.
We next examined the role of EC cholesterol efflux pathways in atherogenesis. We used male mice for these studies, because we previously observed that vascular Abcg1 deficiency decreased eNOS activity in male, but not in female mice, 28 possibly reflecting an estrogen effect. 38 Ldlr −/− , EC-ABC A1KO Ldlr −/− , EC-ABC G1KO Ldlr −/− , and EC-ABC DKO Ldlr −/− mice were fed the WTD. Total plasma cholesterol levels were similar in all groups of mice as were HDL-cholesterol levels (Table) . Unlike models with hematopoietic or macrophage Abca1/g1 deficiency, 33 EC-Abca1/g1 deficiency did not affect blood leukocyte levels ( Figure IV in the online-only Data Supplement). After 20 to 22 weeks of WTD feeding, we euthanized the mice and assessed atherosclerotic lesion area at the level of the aortic root. Both EC-Abca1 and EC-Abcg1 deficiency significantly increased atherosclerotic lesion area compared with the Ldlr −/− controls; combined EC-Abca1/g1 deficiency caused a significant further increase in lesion area ( Figure 2C ). We then assessed atherosclerotic lesion area in the whole aorta by performing en face analysis using Oil Red O staining. Both single and combined EC-Abca1 and EC-Abcg1 deficiency increased atherosclerotic lesion area compared with the Ldlr −/− controls ( Figure 2D ; Figure V in the online-only Data Supplement). EC-Abca1 and EC-Abcg1 deficiency increased atherosclerosis in the whole aorta to a larger extent than in the aortic root; the effects being most dramatic in combined EC-Abca1/g1 deficiency compared with Ldlr −/− controls (P<0.001; Figure 2D ). These findings provide direct evidence that endothelial cholesterol efflux pathways mediated by both ABCA1 and ABCG1 suppress atherosclerosis in mice and that the effects are nonredundant with approximately equal additive contributions in the double knockout.
Nonstandard Abbreviations and Acronyms
EC-Abca1 and Abcg1 Deficiency Accelerates Atherosclerosis in Aortic Branch Areas
Because the effects on atherosclerosis were most pronounced in the setting of combined EC-Abca1/g1 deficiency, we used EC-ABC DKO Ldlr −/− mice and Ldlr −/− controls for our subsequent studies. We performed a short-term atherosclerosis study by feeding EC-ABC DKO Ldlr −/− and Ldlr −/− mice the WTD for 12 weeks. Similar to our findings in the 20to 22-week study ( Figure 2C ), EC-Abca1/g1 deficiency increased atherosclerotic lesion area in the aortic root ( Figure 3A ). Interestingly, EC-Abca1/g1 deficiency markedly increased lipid accumulation in the branches of the aorta (4.7-fold; P<0.001; Figure 3B and 3C). We observed this lipid accumulation specifically in EC-ABC DKO Ldlr −/− mice; only one of the Ldlr −/− control mice showed detectable lipid accumulation in the branch areas ( Figure 3B and 3C). We stained the sections of the aorta for the macrophage marker mac3 and found that EC-Abca1/g1 deficiency also increased mac3 staining in the vessel wall of the aortas ( Figure 3C and 3D). The areas showing lipid accumulation corresponded to those positive for mac3 staining ( Figure 3C ), suggesting macrophage foam cell formation. These data indicate that EC-Abca1/g1 deficiency dramatically increases the onset of atherosclerosis in the branches of the aorta that are exposed to disturbed blood flow.
EC-Abca1 and Abcg1 Deficiency Decreases eNOS Activity and Increases Lipopolysaccharide-Induced Expression of Inflammatory Genes
Our previous studies have shown that on cholesterol-rich diets, combined deficiency of Abca1/g1 or Abcg1 deficiency alone led to decreased endothelium-dependent vasorelaxation in femoral arteries, which we attributed to endothelial Abca1/g1 or Abcg1 deficiency and decreased eNOS activity; however, a contribution of other vascular cells could not be excluded. 18, 28 We tested this hypothesis in our EC-Abca1/g1-deficient model. EC-ABC DKO Figure 3E ), reflecting decreased eNOS activity. We then assessed eNOS-mediated NO production in aortic ECs isolated from EC-ABC DKO Ldlr −/− and Ldlr −/− mice using the NO-specific fluorescent dye 4,5-diaminofluorescein diacetate. Abca1/g1 deficiency decreased the percentage of 4,5-diaminofluorescein diacetate-positive cells by ≈40% (*P<0.05; Figure 3F ), reflecting reduced NO production. These results indicate that our previous findings regarding decreased endothelium-dependent vasorelaxation in Abca1 −/− Abcg1 −/− mice on WTD 18 were most likely the consequence of decreased eNOS activity in Abca1/g1-deficient ECs. Deficiency of eNOS has been reported to moderately increase blood pressure. 39 However, we did not find any effect of EC-Abca1/g1 deficiency on blood pressure at several time points after the start of the WTD feeding ( Figure VI in the online-only Data Supplement), likely reflecting our finding that eNOS activity was decreased by ≈40% to 50% ( Figure 3E and 3F), whereas a moderate increase in blood pressure depends on complete eNOS deficiency. 39 Hypercholesterolemia, or treatment with a low dose of lipopolysaccharide, in Ldlr −/− mice increases endothelial nuclear factor-κB (NF-κB) activation in regions of the aorta exposed to disturbed blood flow, 13 predisposing these sites to atherosclerosis. To investigate a role for Abca1/g1 in endothelial inflammation, we isolated aortic ECs from the EC-ABC DKO Ldlr −/− mice and Ldlr −/− controls and incubated them with lipopolysaccharide. EC-Abca1/g1 deficiency enhanced the lipopolysaccharide-induced mRNA expression of Vcam-1, Icam-1, monocyte chemoattractant protein-1 (Mcp-1) , interleukin-1β (Il-1β), tumor necrosis factor α (Tnf-α), and Il-6 ( Figure 4A ). To examine whether these changes would contribute to monocyte infiltration in atherosclerotic plaques, EC-ABC DKO Ldlr −/− and Ldlr −/− mice were fed WTD for 12 weeks and injected with FITC + beads that accumulate in monocytes. 40 The percentage of FITC + beads incorporated in blood monocytes was similar between mice from both genotypes ( Figure 4B ), but EC-ABC DKO Ldlr −/− mice showed an ≈50% increase in FITC + bead accumulation in macrophage-positive areas of the atherosclerotic plaques compared with their Ldlr −/− controls, reflecting enhanced monocyte infiltration ( Figure 4C ; Figure VII in the online-only Data Supplement). We then asked whether cholesterol efflux pathways also regulate inflammatory gene expression in HAECs. As shown previously, in HAECs ABCG1 is the main transporter mediating cholesterol efflux to HDL, whereas ABCA1 expression is almost undetectable. 18 We efficiently knocked down ABCG1 in HAECs using siRNA 18, 24 and incubated HAECs with lipopolysaccharide or the proatherogenic cytokine TNF-α. ABCG1 knockdown enhanced both lipopolysaccharide-induced and TNF-α-induced expression of VCAM-1, ICAM-1, and MCP-1 in HAECs ( Figure 4D and 4E) . We then assessed whether these increases resulted in enhanced monocyte adhesion and coincubated ABCG1 and scrambled siRNA-treated HAECs with FITC + monocytes during the lipopolysaccharide exposure. ABCG1 knockdown in HAECs markedly enhanced the lipopolysaccharide-induced monocyte adhesion to the EC monolayer ( Figure 4F ).
Together, these findings show that endothelial Abca1/ g1 deficiency decreased eNOS activity in aortas of WTD-fed mice and NO production in aortic ECs. NO has been shown to be antiatherogenic by decreasing cytokine-induced NF-κB activation in ECs, resulting in decreased EC vascular adhesion molecules and monocyte adhesion. 41 Endothelial Abca1/g1 deficiency also increased lipopolysaccharide-induced inflammatory gene expression in aortic ECs and monocyte infiltration into atherosclerotic plaques. The findings on inflammatory gene expression are recapitulated in HAECs and resulted in enhanced monocyte adhesion, indicating that the findings in mice also may be relevant to humans. These observations likely explain the increased atherosclerosis in EC-Abca1/g1 deficiency.
EC-Abca1 and Abcg1 Deficiency Enhance New Vessel Sprouting in Aortic Rings
Recent studies have suggested that cholesterol efflux pathways regulate angiogenesis in zebrafish and that deficiency of Abca1 and Abcg1 causes excessive angiogenesis, impairing proper development and growth. 32 Whether cholesterol efflux pathways play a role in modulating angiogenesis in mammals is unclear. ECs play a key role in angiogenesis, 42 and angiogenesis worsens advanced atherosclerosis in mice. 43 We evaluated the role of endothelial Abca1/g1 expression in new vessel sprouting in aortic rings ex vivo. Aortic rings were embedded in matrigel and incubated with endothelial growth factors. After 5 days, we observed increased new vessel sprouting in EC-Abcg1-and EC-Abca1/g1-deficient aortic rings, but not in EC-Abca1-deficient aortic rings, compared with controls ( Figure 5A and 5B) , suggestive of increased angiogenesis. We then examined whether increased vessel sprouting in EC-Abca1/g1-deficient aortas could have played a role in the increased atherosclerosis in EC-ABC DKO Ldlr −/− mice. Using von Willebrand factor staining, we observed only a few new blood vessels in the intima or adventitia of advanced atherosclerotic lesions in EC-ABC DKO Ldlr −/− mice and their controls, with no difference between the genotypes ( Figure VIII in the online-only Data Supplement). We performed further in vivo studies on the role of cholesterol efflux pathways in angiogenesis in mice, using the retinal angiogenesis assay that can be used as a model for angiogenesis during development, 44 but these studies showed no effect of EC-Abca1 and Abcg1 on angiogenesis ( Figure 5C and 5D; Figure IX in the online-only Data Supplement). Together, these results demonstrated that EC-Abca1/g1 deficiency enhanced angiogenesis in aortic rings ex vivo but not during retina vascular developments in vivo. Our data demonstrated that unlike in zebrafish, EC cholesterol efflux pathways may not be essential for proper angiogenesis during development in mice; however, this issue deserves further exploration. The observations on new vessel formation in atherosclerotic lesions suggest that this mechanism does not play a role in the increased atherosclerosis in EC-ABC DKO Ldlr −/− mice. Previous studies have suggested that 36 to 60 weeks of cholesterol-rich diet feeding is required to observe angiogenesis in lesions of Apoe −/− mice, 43 presumably explaining why we only observed a few new vessels in the Ldlr −/− model fed the WTD for 20 to 22 weeks.
Discussion
This study shows that cholesterol efflux pathways mediated by both ABCA1 and ABCG1 in ECs are antiatherogenic and have a key role in preserving eNOS activity and suppressing endothelial inflammation. Although we previously showed that cholesterol efflux pathways are involved in maintaining eNOS activity, 18 we here demonstrated that this is specifically because of their action in ECs, leading to suppression of atherosclerosis. Our studies provide strong support for the idea that the beneficial effects of infusion of HDL on endothelial function 20, 23 are mediated at least in part by promotion of cholesterol efflux from, and restoration of eNOS activity in, ECs.
Interestingly, in ECs, not only combined Abca1/g1 deficiency accelerates atherosclerosis, but also single Abca1 or Abcg1 deficiency (Figure 2) . This is strikingly different to macrophages, in which single deficiencies of Abca1 or Abcg1 do not increase atherosclerosis. 27, [45] [46] [47] Likely this is because deletion of Abca1 leads to upregulation of Abcg1 expression and vice versa, 27 so that only the combined deficiency of macrophage Abca1/g1 accelerates atherosclerosis. 33 Why such compensation occurs in macrophages and presumably not ECs is unclear but could perhaps be related to the ability of macrophages to store cholesterol and increase endogenous liver X receptor ligands. 48 One study addressed the role of endothelial ABCA1 in atherosclerosis using an endothelium-specific ABCA1 overexpression mouse model. 49 Surprisingly, endothelial ABCA1 overexpression increased HDL-cholesterol levels by ≈40%, potentially because of a 2.6-fold increase in EC cholesterol efflux to apolipoprotein A1 compared with controls. 49 In contrast, we found no effect of endothelial Abca1 deficiency on HDL levels (Table) . The increased HDL levels most likely explain why endothelial ABCA1 overexpression reduced atherosclerosis in this model 49 and hamper interpretation as to whether EC-ABCA1 affected atherosclerosis locally in the vessel wall. Several studies have shown that scavenger receptor BI plays a role in the HDL-preserving effects on eNOS activity and endothelial function, possibly by mediating the efflux of oxysterols and cholesterol from ECs to HDL. 11, [15] [16] [17] Srb1 −/− mice show reduced endothelium-dependent vasorelaxation, 16 and Srb1 deficiency accelerates atherosclerosis in Apoe −/− mice. 50 Endothelial Srb1 deficiency could have contributed to this effect; however, Srb1 deficiency also increased proatherogenic VLDL (very low-density lipoprotein)-sized cholesterolenriched particles and led to abnormally enlarged HDL. 50 The significance of the endothelium-preserving effects of scavenger receptor BI for atherogenesis thus remains to be directly tested in an endothelium-specific Srb1-deficient mouse model.
We found that EC-Abca1/g1 deficiency especially increased the onset of atherosclerosis in the branches of the aorta (Figure 3 ) that are exposed to disturbed blood flow. Abca1 is upregulated in aortic arch ECs after a proatherogenic stimulus, 31 suggesting a particular antiatherogenic role for the Abca1 transporter in this region of the aorta. Interestingly, a proatherogenic stimulus involving either lipopolysaccharide or proatherogenic diet feeding increased NF-κB activation particularly at sites of the aorta exposed to disturbed blood flow, suggesting a link between EC cholesterol accumulation and NF-κB activation in these regions. We explored this link in Abca1/g1-deficient aortic ECs. EC-Abca1/g1 deficiency enhanced lipopolysaccharide-induced expression of NF-κB target genes (Figure 4 ), possibly because of enhanced surface expression of Toll-like receptor 4 in lipid rafts, similar to our previous observations in macrophages. 51 Interestingly, EC-Abca1/g1 deficiency also enhanced monocyte infiltration in atherosclerotic plaques in vivo ( Figure 4 ) and particularly enhanced macrophage foam cell formation at sites of disturbed blood flow ( Figure 3D ). Together, these findings provide evidence for the idea 13 that endothelial cholesterol accumulation contributes to the initiation of atherogenesis in regions of the aorta exposed to disturbed blood flow.
In sum, our studies demonstrate an atheroprotective role of endothelial cholesterol efflux pathways mediated by ABCA1 and ABCG1 that help to maintain eNOS activity and suppress endothelial inflammation. We cannot exclude a possible contribution of other actions of these transporters to our results, such as effects of ABCG1 on intracellular cholesterol homeostasis. 52, 53 These studies add to the understanding of the atheroprotective effects of HDL and liver X receptor activators. Liver X receptor activators could be antiatherogenic in part by increasing Abca1/g1 expression in ECs. Infusions of cholesterol-poor reconstituted HDL that are currently in clinical trials for atherothrombosis 54 are likely to exert beneficial effects by stimulating endothelial cholesterol efflux mediated by ABCA1/G1 and other pathways.
